500 patients67,039 observations150 daysLIVE

Patient P-03204

Synthetic patientONX-7 · Day 140 · 55–64 · F · baseline S16Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Stable
Discontinuation risk
26%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S16
  2. Day 90 AD-05 recommendedAdherence Support AD-05
  3. Day 91 Patient acceptedStarted AD-05 in the companion
  4. Day 96 GI symptom burden −11% vs expectedAdherence Support AD-05
  5. Day 102 Tolerance state changedUnstable → Improving
  6. Day 109 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 109.

Primary contributors, last 14 days
  • Toxicity+16
  • Inflammatory activity+12
  • GI instability+5
  • Treatment adherence+4
  • Nutritional resilience-3

What helped?

  • Adherence Support AD-05Day 90
    Result: symptom burden −11%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
5.5/10
stable · +0.1 vs previous 14 d
Stress level
Daily log
4.1/10
stable · 0.0 vs previous 14 d
Pessimism score
Daily log
4/10
improving · -0.2 vs previous 14 d
Sleep quality
Wearable
58.8/100
worsening · -2.7 vs previous 14 d
Libido
Daily log
5/10
worsening · -0.4 vs previous 14 d
HRV
Wearable
51.9 ms
worsening · -3.1 vs previous 14 d
Toxicity
Blood
21.3/100
worsening · +2.8 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 61 from the failing basin, 33 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -3.4 next day on high-intake days · n 17
Would not help
  • AD-05 Adherence Support
    already tried, no meaningful change
  • Keep lactose low
    GI +3.2 next day on high-intake days · n 23
  • Keep alcohol low
    GI +1.8 next day on high-intake days · n 19
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -3.4supporter · 95%
  • Lactose
    +3.2detractor · 95%
  • Alcohol
    +1.8detractor · 56%
  • Dietary fat load
    +1.4no signal · 37%
  • Histamine load
    +1no signal · 22%
  • Caffeine
    0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Autonomic recovery 25
    • WearableResting HR 75 bpm
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Rapid metabolizer
    Expected exposure
Microbiome
Shannon diversity 3.8 · butyrate capacity 72/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
55 ms
Sleep
7.8 h
Steps
5,921
Resting HR
75 bpm
Daily log: GI score 26, nutritional resilience 59, adherence 87.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Keep fibre steady; no new sources this week
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0337544%S09DT-01improved52
P-0327743%S14BR-03improved41
P-0314442%S16HY-01improved52
P-0317942%S05GI-04improved52
P-0338041%S16AD-05improved34
P-0342440%S12AD-05improved41
P-0340839%S09HY-01improved53
P-0348439%S07DT-01improved49
P-0317838%S11GI-04improved54
P-0319338%S13DT-01improved53
P-0326838%S15DT-01improved56
P-0339238%S15GI-04improved52